port with a twisting motion until the pin is firmly seated.
NOTE: See full directions on administration set carton.
6.Lift the free end of the hanger loop on the bottom of the vial, breaking the two tie strings. Bend the loop outward to lock it in the upright position, then suspend container from hanger.
7.Squeeze and release drip chamber to establish proper fluid level in chamber.
8.Open flow control clamp and clear air from set. Close clamp.
9.Attach set to venipuncture device. If device is not indwelling, prime and make venipuncture.
10.Regulate rate of administration with flow control clamp.
WARNING: Do not use flexible container in series connections.
At concentrations ranging from 10 to 40 mg/mL in 0.9% Sodium Chloride Injection, USP, Oxacillin will have utility times of 4 days at room temperature (25°C).
In 5% Dextrose Injection, USP, at concentrations from 10 to 40 mg/mL Oxacillin will have utility times of 6 hours at room temperature (25°C).
HOW SUPPLIEDOxacillin for Injection, USP ADD-Vantage® for intravenous use contains oxacillin sodium equivalent to 1 or 2 grams oxacillin per vial.
NDC 0781-3094-92 — 1 gram ADD-Vantage® Vial, packed in 10s
NDC 0781-3095-92 — 2 gram ADD-Vantage® Vial, packed in 10s
Store dry powder at 20°-25°C (68°-77°F) [See USP Controlled Room Temperature].
ADD-Vantage® is a trademark of Hospira Inc.
06-2011M
46060946
Manufactured in Austria by Sandoz GmbH
for Sandoz Inc., Princeton, NJ 08540
1 gram LabelNDC 0781-3094-15
ADD-Vantage® vial
Oxacillin
for Injection, USP
1 gram Rx only
Buffered — For IV use
For use only with the
ADD-Vantage® diluent container.
SANDOZ
(click image for full-size original)
Oxacillin for Injection 1 gram Label
2 gram Label
NDC 0781-3095-15
ADD-Vantage® vial
Oxacillin
for Injection, USP
2 grams Rx only
Buffered — For IV use
For use only with the
ADD-Vantage® diluent container.
SANDOZ
(click image for full-size original) OXACILLIN
oxacillin injection, powder, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0781-3094
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
OXACILLIN SODIUM (OXACILLIN) OXACILLIN 1 g
Inactive Ingredients
Ingredient Name Strength
SODIUM PHOSPHATE, DIBASIC
Packaging
Item Code Package Description Multilevel Packaging
1 NDC:0781-3094-92 10 VIAL (VIAL) in 1 PACKAGE contains a VIAL (0781-3094-15)
1 NDC:0781-3094-15 1 INJECTION, POWDER, FOR SOLUTION (VIAL) in 1 VIAL This package is contained within the PACKAGE (0781-3094-92)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA062737 12/23/1986
OXACILLIN
oxacillin injection, powder, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0781-3095
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
OXACILLIN SODIUM (OXACILLIN) OXACILLIN 2 g
Inactive Ingredient
